OBJECTIVE: To assess the effects of the side of implantation (first-side vs second-side vestibular schwannoma); the presence of nonauditory sensations; the general health, expectations, and motivation of the patients; and a support group on the use of a multichannel auditory brainstem implant (ABI) in 12- to 18-year-old patients with neurofibromatosis 2. DESIGN: Since 1992, 21 individuals (age range, 12-18 years) who were deafened by neurofibromatosis 2 have undergone implantation with a multichannel ABI at the House Ear Institute, Los Angeles, Calif. The patients were categorized regarding side of implantation, presence of remaining hearing (in first-side implant recipients), incidence of nonauditory sensations, and ABI use or nonuse. They were also rated on factors of general health, personal motivation, expectations, and family support. RESULTS: Nineteen (95%) of 20 teenagers tested received hearing sensations from their ABIs. Eleven teenagers used their ABIs regularly, but 8 did not. Of the nonusers, 2 had good remaining hearing on the side with the second vestibular schwannoma, 2 had persistent nonauditory sensations, and 4 became program dropouts. None of the dropouts had remaining hearing, significant nonauditory sensations, or poor health; however, they generally rated poorly in terms of personal motivation, expectations, and family support. One patient with good family support returned with excellent ABI results after 4 years' absence. CONCLUSIONS: The multichannel ABI is an effective means of providing hearing sensations to young patients deafened by neurofibromatosis 2. Preoperative counseling regarding the importance of such factors as expectations, personal motivation, and family support is invaluable and can promote successful adaptation to the device. With patience and support, even young nonusers (including program dropouts) can become successful device users.
OBJECTIVE: To assess the effects of the side of implantation (first-side vs second-side vestibular schwannoma); the presence of nonauditory sensations; the general health, expectations, and motivation of the patients; and a support group on the use of a multichannel auditory brainstem implant (ABI) in 12- to 18-year-old patients with neurofibromatosis 2. DESIGN: Since 1992, 21 individuals (age range, 12-18 years) who were deafened by neurofibromatosis 2 have undergone implantation with a multichannel ABI at the House Ear Institute, Los Angeles, Calif. The patients were categorized regarding side of implantation, presence of remaining hearing (in first-side implant recipients), incidence of nonauditory sensations, and ABI use or nonuse. They were also rated on factors of general health, personal motivation, expectations, and family support. RESULTS: Nineteen (95%) of 20 teenagers tested received hearing sensations from their ABIs. Eleven teenagers used their ABIs regularly, but 8 did not. Of the nonusers, 2 had good remaining hearing on the side with the second vestibular schwannoma, 2 had persistent nonauditory sensations, and 4 became program dropouts. None of the dropouts had remaining hearing, significant nonauditory sensations, or poor health; however, they generally rated poorly in terms of personal motivation, expectations, and family support. One patient with good family support returned with excellent ABI results after 4 years' absence. CONCLUSIONS: The multichannel ABI is an effective means of providing hearing sensations to young patients deafened by neurofibromatosis 2. Preoperative counseling regarding the importance of such factors as expectations, personal motivation, and family support is invaluable and can promote successful adaptation to the device. With patience and support, even young nonusers (including program dropouts) can become successful device users.
Authors: Eric P Wilkinson; Laurie S Eisenberg; Mark D Krieger; Marc S Schwartz; Margaret Winter; Jamie L Glater; Amy S Martinez; Laurel M Fisher; Robert V Shannon Journal: Otol Neurotol Date: 2017-02 Impact factor: 2.311
Authors: Steven R Otto; Jean Moore; Fred Linthicum; William Hitselberger; Derald Brackmann; Robert V Shannon Journal: Laryngoscope Date: 2012-01-17 Impact factor: 3.325
Authors: Alyson B Kaplan; Elliott D Kozin; Sidharth V Puram; Maryanna S Owoc; Parth V Shah; A E Hight; Rosh K V Sethi; Aaron K Remenschneider; Daniel J Lee Journal: Int J Pediatr Otorhinolaryngol Date: 2014-12-15 Impact factor: 1.675
Authors: Mohan Kameswaran; M C Vasudevan; R S Anand Kumar; Jawahar Nagasundaram; Kiran Natarajan; S Raghunandhan Journal: Indian J Otolaryngol Head Neck Surg Date: 2005-01
Authors: Kunal R Shetty; Sarah E Ridge; Vivek Kanumuri; Angela Zhu; M Christian Brown; Daniel J Lee Journal: World J Otorhinolaryngol Head Neck Surg Date: 2021-04-06
Authors: Katherine N Gibson-Corley; Oliver Flouty; Hiroyuki Oya; George T Gillies; Matthew A Howard Journal: Biomed Res Int Date: 2014-04-01 Impact factor: 3.411